Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: Implications for treatment and prophylaxis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages 2709-2715

  Cipriani, Cristiana ^a   Romagnoli, Elisabetta ^a   Pepe, Jessica ^a   Russo, Stefania ^a   Carlucci, Luciano ^a   Piemonte, Sara ^a   Nieddu, Luciano ^b   McMahon, Donald J ^c   Singh, Ravinder ^d   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Rome University of International Studies   (Italy)

^c Columbia University ^*  (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 24,25 HYDROXYVITAMIN D2; 24,25 HYDROXYVITAMIN D3; 25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TREATMENT PLANNING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

24,25-DIHYDROXYVITAMIN D 3; 25-HYDROXYVITAMIN D 2; ADMINISTRATION, ORAL; AGED; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CALCIFEDIOL; CHOLECALCIFEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERGOCALCIFEROLS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY;

EID: 84879972323     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1586     Document Type: Article

References (42)

1. Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2013;92:128-139.
2. Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab. 2011;96:1560-1567.
3. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7:439-443. (Pubitemid 27443069)
4. Garg MK, Marwaha RK, Khadgawat R, et al. Efficacy of vitamin D loading doses on serum 25-hydroxy vitamin D levels in school going adolescents: an open label non-randomized prospective trial. J Pediatr Endocrinol Metab. 2013;26:515-523.
5. Carnevale V, Modoni S, Pileri M, et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int. 2001;12:1026-1030. (Pubitemid 34105973)
6. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25:671-680.
7. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777-783. (Pubitemid 28135983)
8. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr. 1999;81:133-137. (Pubitemid 29103621)
9. Cranney A, Weiler HA, O'Donnel S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone. Am J Clin Nutr. 2009;88:513S-519S.
10. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.
11. Binkley N, Gemar D, Engelke J, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011;96:981-988.
12. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol. 2010;2010:579640.
13. Carter GD. 25-Hydroxyvitamin D: a difficult analyte. Clin Chem. 2012;58:486-488.
14. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011.
15. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
16. Adami S, Romagnoli E, Carnevale V, et al. Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo. 2011;63:129-1247.
17. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326:469.
18. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815-1822.
19. Smith H, Anderson F, Raphael H, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46:1815-1822.
20. 3, and total 25-hydroxyvitamin D in a clinical setting. Endocr Pract. 2012;18:399-402.
21. Binkley N, Krueger D, Lensmeyer G. 25-Hydroxyvitamin D measurement, 2009: a review for clinicians. J Clin Densitom. 2009;12:417-427.
22. 3) in the elderly. J Clin Endocrinol Metab. 2008;93:3015-3020.
23. Cipriani C, Romagnoli E, Scillitani A, et al. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab. 2010;95:4771-4777.
24. Walton RJ, Bijvoet OL. Nomogramfor derivation of renal threshold phosphate concentration. Lancet. 1975;2:309-310.
25. Carnevale V, Dionisi S, Nofroni I, et al. Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem. 2004;50:626-631. (Pubitemid 38297315)
26. 2 in human serum. In: Proceedings of American Society for Bone and Mineral Research Annual Meeting; October 12-15, 2012; Minneapolis, MN. Abstract.
27. Hanwell NE, Vieth R, Cole DE, et al. Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy. J Steroid Biochem Mol Biol. 2010;121:334-337.
28. Carnevale V, Potenza A, Romagnoli E, Modoni S, Chiodini I, Scillitani A. Evaluation of calcium and vitamin D dietary intake in a sample of normal subjects. In: Italian Society of Osteoporosis and Metabolic Bone Disease Annual Meeting, October 11-14, 2000; Abano Terme, Padova, Italy. Abstract.
29. Whyte MP, Haddad JG Jr, Walters DD, Stamp TC. Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. J Clin Endocrinol Metab. 1979;48:906-911. (Pubitemid 9190839)
30. 3 in humans. J Clin Endocrinol Metab. 2004;89:5387-5391.
31. 2 in humans. J Clin Endocrinol Metab 96:E447-E452, 2011.
32. 2) as a vitamin supplement. Am J Clin Nutr. 2006;84:694-697.
33. 3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95:1357-1364.
34. Hansen KE. High-dose vitamin D: helpful or harmful? Curr Rheumatol Rep. 2011;13:257-2564.
35. Minisola S, Colangelo L, Cilli M, Cipriani C, Pepe J, Romagnoli E. Intermittent high doses of vitamin D: A need for further studies? Calcif Tissue Int. 2013;92:487-488.
36. Einarsdóttir K, Preen DB, Clay TD, Kiely L, Holman CD, Cohen LD. Effect of a single 'megadose' intramuscular vitamin D (600,000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg. 2010;20:732-737.
37. Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/mL). Best Pract Res Clin Endocrinol Metab. 2011;25:681-691.
38. Carnevale V, Nieddu L, Romagnoli E, et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int. 2006;17:478-483.
39. Cavalier E, Wallace AM, Knox S, Mistretta VI, Cormier C, Souberbielle JC. Serum vitamin D measurement may not reflect what you give to your patients. J Bone Miner Res. 2008;23:1864-1865.
40. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007;22:V64-V68. (Pubitemid 351304652)
41. 3. J Clin Endocrinol Metab. 2012;97:E622-E626.
42. Levin GP, Robinson-Cohen C, de Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012;308:1898-1905.